Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05909618
Status:
RECRUITING
Last Update Posted:
2023-11-28
First Post:
2023-05-01
Brief Title:
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Sponsor:
Sheba Medical Center
Organization:
Sheba Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-01
First Submit QC Date:
June 11 2023
Study First Post Date:
2023-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-22
Last Update Post Date:
2023-11-28
Last Update Post Date Type:
ACTUAL